AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause
AMAG PHARMACEUTICALS (AMAG)
Last amag pharmaceuticals earnings: 3/4 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
amagpharma.com/investors
Company Research
Source: GlobeNewswire
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today commended the recent action taken by the Centers for Medicare and Medicaid Services (CMS) to clarify statutory intent of section §1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy (VVA), due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling. This clarification should expand treatment options covered under Part D to include Intrarosa® (prasterone) vaginal inserts, the only locally administered, non-estrogen treatment alternative available to reduce moderate to severe dyspareunia due to menopause without an FDA boxed safety warning. VVA, also referred to as genitourinary syndrome of menopause (GSM), is a chronic and progressive medical condition that is common in postmenopausal women due to decreases i
Show less
Read more
Impact Snapshot
Event Time:
AMAG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMAG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMAG alerts
High impacting AMAG PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics